Quanterix Simoa Technology Powers Multiple Sclerosis Research with More Than 50 Presentations at ECTRIMS 2019
Quanterix Corporation (QTRX)
US:NASDAQ Investor Relations:
ir.quanterix.com/investor-relations
Company Research
Source: Business Wire
Record-breaking number of presentations and abstracts at International Multiple Sclerosis conference demonstrates promise and relevance of Neurofilament light chain (Nf-L) as a reliable disease biomarker for MS BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today announced that its ultra-sensitive Simoa technology has been referenced in more than 50 new research studies to be presented at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), from Sept. 11-13, 2019 in Stockholm, Sweden. The number of presentations leveraging Simoa increased by over 40 percent since last year’s event, demonstrating widespread adoption of Quanterix’ technology by leading researchers dedicated to advancing disease diagnosis and monitoring for Multiple Sclerosis. In addition to the growing number of abstracts and posters at ECTRIMS and other majo
Show less
Read more
Impact Snapshot
Event Time:
QTRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
QTRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
QTRX alerts
High impacting Quanterix Corporation news events
Weekly update
A roundup of the hottest topics
QTRX
News
- Quanterix To Report First Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Quanterix To Report First Quarter 2024 Financial ResultsBusiness Wire
- Quanterix Co. (NASDAQ: QTRX) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $32.00 to $25.00. They now have a "buy" rating on the stock.MarketBeat
- Investing in Quanterix (NASDAQ:QTRX) a year ago would have delivered you a 111% gain [Yahoo! Finance]Yahoo! Finance
- Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer's Disease Testing Infrastructure [Yahoo! Finance]Yahoo! Finance
QTRX
Earnings
- 2/29/24 - Miss
QTRX
Sec Filings
- 5/1/24 - Form 4
- 4/17/24 - Form 4
- 4/15/24 - Form ARS
- QTRX's page on the SEC website